Karaboga, B. And ÇİLLİ, A. 2015. Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia. TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.63, no.2 , 94-101.

Karaboga, B., & ÇİLLİ, A., (2015). Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia. TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.63, no.2, 94-101.

Karaboga, Burcu, And AYKUT ÇİLLİ. "Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia," TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.63, no.2, 94-101, 2015

Karaboga, Burcu And ÇİLLİ, AYKUT. "Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia." TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.63, no.2, pp.94-101, 2015

Karaboga, B. And ÇİLLİ, A. (2015) . "Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia." TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX , vol.63, no.2, pp.94-101.

@article{article, author={Burcu Karaboga And author={AYKUT ÇİLLİ}, title={Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia}, journal={TUBERKULOZ VE TORAK-TUBERCULOSIS AND THORAX}, year=2015, pages={94-101} }